Original Research

The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia

Wang S, Wang X, Liu S, Zhang S, Wei X, Song Y, Yin Q

OncoTargets and Therapy 2020, 13:6583-6591

Published Date: 6 July 2020